CellCentric, ZoBio in epigenetic deal

CellCentric Ltd. (Cambridge, U.K.) and ZoBio B.V. (Leiden, the Netherlands) partnered to develop compounds against epigenetic drug targets. ZoBio will use its Target Immobilized NMR Screening technolo...